Exposure to rufinamide and risks of CNS adverse events in drug-resistant epilepsy: a meta-analysis of randomized, placebo-controlled trials

Dramatic weight loss with rufinamide

(2012) Isabelle Mourand et al.   EPILEPSIA

Efficacy of Rufinamide in Drug-Resistant Epilepsy: A Meta-analysis

(2011) Alberto Verrotti et al.   PEDIATRIC NEUROLOGY

Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study

(2010) G. Kluger et al.   ACTA NEUROLOGICA SCANDINAVICA

Severe constipation associated with the use of rufinamide (Banzel) in an adolescent

(2010) Kendra Drake et al.   EPILEPSY & BEHAVIOR

A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures

(2010) Christian E. Elger et al.   EPILEPSY RESEARCH

Rufinamide for refractory epilepsy in a pediatric and young adult population

(2010) Jacob R. Joseph et al.   EPILEPSY RESEARCH

Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo-controlled trial

(2009) Martin J. Brodie et al.   EPILEPSIA

Safety and Tolerability of Rufinamide in Children With Epilepsy: A Pooled Analysis of 7 Clinical Studies

(2009) James W. Wheless et al.   JOURNAL OF CHILD NEUROLOGY

Rufinamide: Clinical pharmacokinetics and concentrationresponse relationships in patients with epilepsy

(2008) Emilio Perucca et al.   EPILEPSIA

Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome

(2008) T. Glauser et al.   NEUROLOGY